We are live on ! Find out more
TCM

Twin Capital Management Portfolio holdings

AUM $776M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+28.34%
3 Year Est. Return
+101.5%
5 Year Est. Return
+138.91%
10 Year Est. Return
+461.53%
AUM
$1.08B
AUM Growth
+$80.7M
Cap. Flow
+$2.67M
Cap. Flow %
0.25%
Top 10 Hldgs %
25.16%
Holding
313
New
24
Increased
133
Reduced
124
Closed
25

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$6.76M
2
MAA icon
Mid-America Apartment Communities
MAA
+$5.81M
3
NSC icon
Norfolk Southern
NSC
+$3.75M
4
NVDA icon
NVIDIA
NVDA
+$3.36M
5
MA icon
Mastercard
MA
+$3.3M

Sector Composition

Rank Sector Weight
1 Technology 25.64%
2 Financials 13.82%
3 Healthcare 13.51%
4 Consumer Discretionary 11.11%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
26
United Parcel Service
UPS
$92.7B
$7.89M 0.73%
37,937
-280
-0.7% -$56K
CVX icon
27
Chevron
CVX
$379B
$7.81M 0.72%
74,599
-2,083
-3% -$220K
SPGI icon
28
S&P Global
SPGI
$122B
$7.79M 0.72%
18,988
-1,020
-5% -$392K
ADP icon
29
Automatic Data Processing
ADP
$108B
$7.63M 0.7%
38,408
-667
-2% -$130K
BMY icon
30
Bristol-Myers Squibb
BMY
$135B
$7.29M 0.67%
109,119
+2,120
+2% +$138K
IDXX icon
31
Idexx Laboratories
IDXX
$46.4B
$7.27M 0.67%
11,508
+1,121
+11% +$619K
LLY icon
32
Eli Lilly
LLY
$995B
$7.09M 0.65%
30,877
-8,715
-22% -$1.75M
TMO icon
33
Thermo Fisher Scientific
TMO
$209B
$7.05M 0.65%
13,984
+237
+2% +$112K
QCOM icon
34
Qualcomm
QCOM
$171B
$7.02M 0.65%
49,115
-791
-2% -$107K
INTC icon
35
Intel
INTC
$509B
$6.91M 0.64%
123,120
-28,870
-19% -$1.69M
PFE icon
36
Pfizer
PFE
$145B
$6.8M 0.63%
173,593
+10,440
+6% +$406K
MA icon
37
Mastercard
MA
$500B
$6.75M 0.62%
18,496
-8,872
-32% -$3.3M
PLD icon
38
Prologis
PLD
$130B
$6.67M 0.61%
55,781
-4,035
-7% -$472K
KO icon
39
Coca-Cola
KO
$372B
$6.49M 0.6%
119,971
-450
-0.4% -$24.5K
ALLY icon
40
Ally Financial
ALLY
$13.7B
$6.44M 0.59%
129,159
+2,159
+2% +$111K
TXN icon
41
Texas Instruments
TXN
$259B
$6.34M 0.58%
32,946
+5,330
+19% +$999K
WST icon
42
West Pharmaceutical
WST
$24.5B
$6.29M 0.58%
17,504
+8,764
+100% +$2.9M
GM icon
43
General Motors
GM
$77.5B
$6.28M 0.58%
106,057
+582
+0.6% +$34.2K
IP icon
44
International Paper
IP
$22.4B
$6.26M 0.58%
107,897
+80,019
+287% +$4.57M
PHM icon
45
Pultegroup
PHM
$25.1B
$6.26M 0.58%
114,706
+690
+0.6% +$38.6K
WMT icon
46
Walmart Inc
WMT
$888B
$5.82M 0.54%
123,852
-10,764
-8% -$501K
XOM icon
47
ExxonMobil
XOM
$638B
$5.79M 0.53%
91,702
+245
+0.3% +$14.6K
CSCO icon
48
Cisco
CSCO
$480B
$5.78M 0.53%
109,139
-65
-0.1% -$3.42K
EMR icon
49
Emerson Electric
EMR
$89B
$5.75M 0.53%
59,782
-240
-0.4% -$22.6K
DLR icon
50
Digital Realty Trust
DLR
$71.7B
$5.62M 0.52%
37,377
+33,805
+946% +$5.11M

Similar funds

Twin Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Twin Capital Management held 313 positions worth $1.08B, up 8% from $1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Twin Capital Management's Q2 2021 filing shows 24 new, 133 increased, 124 reduced and 25 closed positions. Its largest new stake was Tyler Technologies: 10,344 shares worth $4.68M. The largest sale was Linde, an estimated $6.76M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Twin Capital Management's largest Q2 2021 buy was Tyler Technologies: 10,344 shares worth $4.68M.
  • Twin Capital Management added most to Digital Realty Trust in Q2 2021, an estimated $5.11M increase.
  • Twin Capital Management's biggest Q2 2021 reduction was Linde, cutting an estimated $6.76M.
  • Twin Capital Management fully exited Norfolk Southern in Q2 2021, selling an estimated $3.75M.
  • Twin Capital Management's ten largest holdings make up 25% of its $1.08B portfolio in Q2 2021.
  • Twin Capital Management opened 24 new positions and closed 25 in Q2 2021.
  • Twin Capital Management's portfolio value rose 8% quarter-over-quarter to $1.08B.

Based on Twin Capital Management's 13F filing for Q2 2021, filed 9 Aug 2021.